Thomas Schmidt
Fortuna: 200 183 $ al 30/06/2026
Fortuna: 200 183 $ al 30/06/2026
Thomas Schmidt currently works at Evaxion AS, as Chief Financial Officer from 2024.
Mr. Schmidt also formerly worked at Ambu A, as Chief Financial Officer from 2022 to 2023 and Roche Pharma AG, as Chief Financial Officer from 2016 to 2020.
Mr. Schmidt received his graduate degree from Copenhagen Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EVAXION A/S 0,15 % | 18/03/2026 | 645.750 ( 0,15 % ) | 200 183 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EVAXION A/S | Director Financiero/CFO | 01/11/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| AMBU A/S | Director Financiero/CFO | 31/12/2023 |
Roche Pharma AG
Roche Pharma AG Medical DistributorsDistribution Services Engages in marketing and distributing prescription medications | Director Financiero/CFO | 01/11/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Ambu A/S
Ambu A/S Medical SpecialtiesHealth Technology Manufactures and markets diagnostic and life supporting devices for hospitals | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Pharma AG
Roche Pharma AG Medical DistributorsDistribution Services Engages in marketing and distributing prescription medications | Distribution Services |
Evaxion Biotech A/S
Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.